Shanghai Henlius Biotech Management Reshuffle
Shanghai Henlius Biotech announces key leadership changes, appointing new secretarial roles to ensure regulatory compliance.
- Latest
- Trending
Shanghai Henlius Biotech announces key leadership changes, appointing new secretarial roles to ensure regulatory compliance.
Ford's EV strategy changes benefit Tesla, Rivian, Lucid by reducing competition and opening market opportunities.
Solana-based DeFi Mango Markets proposes settlement with SEC following $110M exploitation investigation.
Deutsche Bank settles with majority of plaintiffs in Postbank case, reducing legal provisions and impacting third-quarter earnings.
Explore why Thailand's Pension Fund has shifted its investment and hedging strategy amid economic changes.
Westpac's Q3 profits steady as capital earnings rise, despite high rates impacting loan repayments.
ETH approaches resistance, bearish signals from on-chain data and development activity suggest a potential decline.
Ethereum's ETH burn rate drops drastically amid low base fees, impacting network inflation.
MSCI's index adjustment could lead to $2.5 billion inflows into HDFC Bank, thanks to an increase in foreign inclusion factors.
IO Biotech's Q2 2024 EPS beats estimates, reporting -31 cents vs. expected -35 cents, despite no revenue.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.